Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-03-19

Clinical Trial Update: Comparison of Floseal Hemostasis Tonsillectomy With Coblation Tonsillectomy and Cautery Hemostasis Tonsillectomy [Phase 2, Phase 3]

View source ↗

Summary

A Kaiser Permanente Phase 2/Phase 3 trial comparing Floseal Hemostasis during tonsillectomy with Coblation and cautery hemostasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Kaiser Permanente | Conditions: Adenotonsillar Hypertrophy, Tonsillitis | Phase 2, Phase 3 | Status: WITHDRAWN